WORLD PEPTIDEFOUNDATION

Peptide directory

Find a peptide

Public profiles inside a larger governed registry

Search by peptide name, brand, or research code. Open a full evidence profile or the published sources available for a record still in development. Source publication does not mean a completed scientific appraisal.

Browse the Master RegistryExplore research atlasesFind studies worldwide

The registry is an expanding catalog, not a complete list of every peptide. A missing public result does not mean no research exists.

Published profiles

Search profiles and sources

Compare peptides side by side →
Refine by category
Category

1 peptide records

  • Growth hormone-releasing hormone analog

    Tesamorelin

    Peptide analog

    Developing

    Matched on: name

    Tesamorelin is a stabilized N-terminally modified analog of the 44-amino-acid human growth hormone–releasing hormone. It activates pituitary GHRH receptors, increasing endogenous growth-hormone release and downstream IGF-1 signaling. In the labeled population this pathway reduces visceral adipose tissue; it is not a general weight-loss mechanism.

    Evidence and record details

    Evidence integrity map

    Human 16Preclinical 0Durable IDs 28Open signals 3
    Publication state
    Published profile
    Verified source records
    25 source records verified
    Chemistry record
    Chemistry record on file
    Regulatory entries
    1 published regulatory entry
    Research questions
    24 open research questions
    Evidence review date
    Documented human review recorded Sep 8, 2026

    Source verification checks records; it does not itself approve scientific conclusions.

    View evidence profile for Tesamorelin
How the public directory relates to the 500-record Master Registry

master registry transparency

500 master records, with governance status shown explicitly

WPF-MASTER-REGISTRY-TRANSPARENCY-1.0
501
Master records
467
Governed records
34
Review-deferred
458
Peptide acquisition eligible
9
Governed comparators

The master registry has 467 governed identities from 501 records. 34 remain review-gated. Nine governed records are scientific comparators, leaving 458 peptide identities in the source acquisition cohort. Database reconciliation is a separate step. The 51 profiles shown on this directory are a represented public-profile subset, not the size of the master registry. All 51 public profiles on this render reconcile to governed peptide identities in that registry; unknown, duplicate, deferred, or comparator identities fail closed instead of appearing publicly.

Explore the full Master Registry →
What the profile status labels mean

Evidence, chemistry, and regulatory counts include only records that crossed the relevant public-publication gate. A zero means none published in that lane—not that nothing is known. “No governed record published” is a publication-state disclosure; internal or pending material may exist without appearing in public counts. Source verification, editorial publication, and accountable scientific appraisal are distinct states; a source count alone does not approve a scientific conclusion.

Recently updated public records

When each public profile record was last changed — not clinical or scientific activity.

Peptide Directory — World Peptide Foundation